• Oruka Therapeutics SVP of Finance Arjun Agarwal cut his direct common stock stake to 15,312 shares on July 13, 2026.
• Disposed of 10,299 shares in open-market sales at weighted average prices between $83.07 and $85.63.
• Exercised employee stock options for 9,999 shares at $12.5 and $34.39.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000071), on July 13, 2026, and is solely responsible for the information contained therein.